The allogeneic T and B cell response is strongly dependent on complement components C3 and C4

被引:77
|
作者
Marsh, JE
Farmer, CKT
Jurcevic, S
Wang, Y
Carroll, MC
Sacks, SH
机构
[1] Kings Coll London, Guys Hosp, Dept Nephrol & Transplantat, London SE1 9RT, England
[2] Alexion Pharmaceut Inc, Immunobiol Program, New Haven, CT 06511 USA
[3] Ctr Blood Res, Boston, MA USA
关键词
D O I
10.1097/00007890-200110150-00022
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The mechanisms controlling the production of antibodies against histocompatibility antigens are of prime importance in organ transplantation. Methods. We investigated the role of complement in the response to allogeneic stimulation, using mice deficient in C3, C4, or C5 to dissect the role of the alternative, classical, and terminal complement pathways. Results. After fully major histocompatibility complex disparate skin grafts, the allospecific immunoglobulin (Ig)G response was markedly impaired in C3-and C4-, but not in C5-deficient mice. This defect was most pronounced for second set responses. C3-deficient mice also demonstrated a decreased range of IgG isotypes. In contrast, there was no impairment of the allospecific IgM response. In functional T cell assays, the proliferative response and interferon-gamma secretion of recipient lymphocytes restimulated in vitro with donor antigen was decreased two- to threefold in C3-deficient mice. Conclusions. These data show impairment of allogeneic T cell and B cell function in mice with defective complement activation and suggest a predominant role for the classical pathway in stimulating alloimmunity. The terminal pathway seems unimportant in this regard. This extends the results reported for soluble protein antigens and demonstrates a surprisingly marked effect on the alloresponse despite the presence of a stringent antigenic stimulus. These results have implications for the prevention of sensitization in naive transplant recipients.
引用
收藏
页码:1310 / 1318
页数:9
相关论文
共 50 条
  • [1] COMPLEMENT COMPONENTS OF C3 AND C4 IN NIGERIANS
    OLUSI, SO
    MCFARLANE, H
    TROPICAL AND GEOGRAPHICAL MEDICINE, 1975, 27 (03): : 262 - 264
  • [2] Complement Components, C3 and C4, and the Metabolic Syndrome
    Copenhaver, Melanie
    Yu, Chack-Yung
    Hoffman, Robert P.
    CURRENT DIABETES REVIEWS, 2019, 15 (01) : 44 - 48
  • [3] Complement components (C3, C4) in childhood asthma
    Najam F.I.E.
    Giasuddin A.S.M.
    Shembesh A.H.
    The Indian Journal of Pediatrics, 2005, 72 (9) : 745 - 749
  • [4] Complement components (C3, C4) as inflammatory markers in asthma
    Fattah, Mohammed Abdel
    El Baz, Mohammed
    Sherif, Ashraf
    Adel, Alia
    INDIAN JOURNAL OF PEDIATRICS, 2010, 77 (07): : 771 - 773
  • [5] Regulation of early complement components C3 and C4 in the synovium
    Collins, T
    Winkelstein, JA
    Sullivan, KE
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1996, 3 (01) : 5 - 9
  • [6] Complement components (C3, C4) as inflammatory markers in asthma
    Mohammed Abdel Fattah
    Mohammed El Baz
    Ashraf Sherif
    Alia Adel
    The Indian Journal of Pediatrics, 2010, 77 : 771 - 773
  • [7] Molecular Characterization of Complement Components (C3, C4, and Factor B) in Human Saliva
    Akira Andoh
    Yoshihide Fujiyama
    Toshio Kimura
    Hirotugu Uchihara
    Hitoshi Sakumoto
    Hidetoshi Okabe
    Tadao Bamba
    Journal of Clinical Immunology, 1997, 17 : 404 - 407
  • [8] Molecular characterization of complement components (C3, C4, and factor B) in human saliva
    Andoh, A
    Fujiyama, Y
    Kimura, T
    Uchihara, H
    Sakumoto, H
    Okabe, H
    Bamba, T
    JOURNAL OF CLINICAL IMMUNOLOGY, 1997, 17 (05) : 404 - 407
  • [9] SMALL-SCALE PREPARATION OF COMPLEMENT COMPONENTS C3 AND C4
    DODDS, AW
    PROTEOLYTIC ENZYMES IN COAGULATION, FIBRINOLYSIS, AND COMPLEMENT ACTIVATION, PART B: COMPLEMENT ACTIVATION, FIBRINOLYSIS, AND NONMAMMALIAN BLOOD COAGULATION FACTORS AND INHIBITORS, 1993, 223 : 46 - 61
  • [10] INFLUENCE OF ANTIPSYCHOTIC TREATMENT ON C3, C4 COMPONENTS OF COMPLEMENT SYSTEM
    Lozano, R.
    Marin, R.
    Pascual, A.
    Freire, I
    Sebastian, F.
    Santacruz, M. J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 111 : 16 - 16